Advisor Shares Investments LLC Cardiol Therapeutics Inc. Transaction History

Advisor Shares Investments LLC

$489 Million
Q1 2025

A detailed history of Advisor Shares Investments LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Advisor Shares Investments LLC holds 982,488 shares of CRDL stock, worth $1.28 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

982,488

Previous 882,488 11.33%

Holding current value

$1.28 Million

Previous $1.14 Million 16.26%

% of portfolio

0.19%

Previous 0.23%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$0.96 - $1.46 $96,000 - $146,000	100,000 Added 11.33%	982,488 $953,000
Q4 2024 Feb 14, 2025	SELL	$1.25 - $2.07 $360,476 - $596,948	-288,381 Reduced 24.63%	882,488 $1.14 Million
Q3 2024 Nov 14, 2024	SELL	$1.83 - $2.48 $541,868 - $734,335	-296,103 Reduced 20.18%	1,170,869 $2.32 Million
Q2 2024 Aug 07, 2024	BUY	$1.67 - $2.97 $275,539 - $490,032	164,994 Added 12.67%	1,466,972 $2.96 Million
Q1 2024 May 14, 2024	BUY	$0.88 - $2.06 $98,560 - $230,720	112,000 Added 9.41%	1,301,978 $2.36 Million
Q4 2023 Feb 13, 2024	SELL	$0.67 - $1.0 $10,592 - $15,810	-15,810 Reduced 1.31%	1,189,978 $999,000
Q3 2023 Nov 06, 2023	SELL	$0.76 - $1.19 $10,602 - $16,600	-13,950 Reduced 1.14%	1,205,788 $1.09 Million
Q2 2023 Aug 09, 2023	BUY	$0.45 - $0.97 $18,000 - $38,800	40,000 Added 3.39%	1,219,738 $1.09 Million
Q1 2023 May 09, 2023	BUY	$0.47 - $0.81 $37,105 - $63,947	78,948 Added 7.17%	1,179,738 $578,000
Q4 2022 Feb 14, 2023	BUY	$0.48 - $1.0 $528,379 - $1.1 Million	1,100,790 New	1,100,790 $561,000
Q1 2021 May 11, 2021	SELL	$2.08 - $4.08 $725,439 - $1.42 Million	-348,769 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$1.84 - $2.64 $113,459 - $162,790	61,663 Added 21.48%	348,769 $970,000
Q3 2020 Nov 12, 2020	BUY	$1.51 - $2.58 $65,839 - $112,493	43,602 Added 17.91%	287,106 $876,000
Q2 2020 Jul 14, 2020	BUY	$1.68 - $2.34 $55,497 - $77,299	33,034 Added 15.7%	243,504 $577,000
Q1 2020 May 13, 2020	BUY	$1.4 - $3.63 $24,906 - $64,577	17,790 Added 9.23%	210,470 $600,000
Q4 2019 Jan 22, 2020	BUY	$1.9 - $3.54 $366,092 - $682,087	192,680 New	192,680 $681,000

Others Institutions Holding CRDL

# of Institutions

Shares Held

7.81M

Call Options Held

25.9K

Put Options Held

1.7K

View Full List

About Cardiol Therapeutics Inc.

Ticker CRDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 61,942,500
Market Cap $80.5M
Description
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...

More about CRDL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Shares Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Shares Investments LLC with notifications on news.

Account

Advisor Shares Investments LLC Cardiol Therapeutics Inc. Transaction History